» Articles » PMID: 38398911

Hybrid Impedimetric Biosensors for Express Protein Markers Detection

Overview
Publisher MDPI
Date 2024 Feb 24
PMID 38398911
Authors
Affiliations
Soon will be listed here.
Abstract

Impedimetric biosensors represent a powerful and promising tool for studying and monitoring biological processes associated with proteins and can contribute to the development of new approaches in the diagnosis and treatment of diseases. The basic principles, analytical methods, and applications of hybrid impedimetric biosensors for express protein detection in biological fluids are described. The advantages of this type of biosensors, such as simplicity and speed of operation, sensitivity and selectivity of analysis, cost-effectiveness, and an ability to be integrated into hybrid microfluidic systems, are demonstrated. Current challenges and development prospects in this area are analyzed. They include (a) the selection of materials for electrodes and formation of nanostructures on their surface; (b) the development of efficient methods for biorecognition elements' deposition on the electrodes' surface, providing the specificity and sensitivity of biosensing; (c) the reducing of nonspecific binding and interference, which could affect specificity; (d) adapting biosensors to real samples and conditions of operation; (e) expanding the range of detected proteins; and, finally, (f) the development of biosensor integration into large microanalytical system technologies. This review could be useful for researchers working in the field of impedimetric biosensors for protein detection, as well as for those interested in the application of this type of biosensor in biomedical diagnostics.

Citing Articles

Hybrid-integrated devices for mimicking malignant brain tumors ("tumor-on-a-chip") for development of targeted drug delivery and personalized therapy approaches.

Zimina T, Sitkov N, Gareev K, Mikhailova N, Combs S, Shevtsov M Front Med (Lausanne). 2024; 11:1452298.

PMID: 39629230 PMC: 11611596. DOI: 10.3389/fmed.2024.1452298.

References
1.
Aydin E, Aydin M, Sezginturk M . A novel electrochemical impedance immunosensor for the quantification of CYFRA 21-1 in human serum. Mikrochim Acta. 2023; 190(6):235. DOI: 10.1007/s00604-023-05813-z. View

2.
Wang C, Li J, Kang M, Huang X, Liu Y, Zhou N . Nanodiamonds and hydrogen-substituted graphdiyne heteronanostructure for the sensitive impedimetric aptasensing of myocardial infarction and cardiac troponin I. Anal Chim Acta. 2020; 1141:110-119. DOI: 10.1016/j.aca.2020.10.044. View

3.
Zhang C, Zhang D, Ma Z, Han H . Cascade catalysis-initiated radical polymerization amplified impedimetric immunosensor for ultrasensitive detection of carbohydrate antigen 15-3. Biosens Bioelectron. 2019; 137:1-7. DOI: 10.1016/j.bios.2019.04.049. View

4.
Shoute L, Abdelrasoul G, Ma Y, Duarte P, Edwards C, Zhuo R . Label-free impedimetric immunosensor for point-of-care detection of COVID-19 antibodies. Microsyst Nanoeng. 2023; 9:3. PMC: 9805445. DOI: 10.1038/s41378-022-00460-5. View

5.
Kamara S, Guo Y, Mao S, Ye X, Li Q, Zheng M . Novel EBV LMP1 C-terminal domain binding affibody molecules as potential agents for in vivo molecular imaging diagnosis of nasopharyngeal carcinoma. Appl Microbiol Biotechnol. 2021; 105(19):7283-7293. DOI: 10.1007/s00253-021-11559-6. View